Medlab Clinical (ASX: MDC)  is a medical life science company developing therapeutic pathways for diagnosed chronic diseases.

The company is focused on the development of therapies for pain management, depression and obesity, as well as earning revenues from the sale of nutritional products in Australia and the United States.

We gave Medlab Clinical’s CEO Dr Sean Hall 90 seconds to provide an overview of the company, its impressive share price performance and the year ahead.

Have a good idea for our next 90 Seconds With segment? Email us at [email protected]